Biopsy Forceps, Polypectomy Snares, and EUS Needle Market Size, Share, and COVID-19 Impact Analysis | Global | 2022-2028 | MedCore | Includes: Biopsy Forceps, Polypectomy Snares, and 1 more

The total global biopsy forceps, polypectomy snare and EUS needle device market is growing at a rate of almost 4%, which will take the 2021 market value of $728 million up to $942 million by 2028.

This full report suite includes the global market for biopsy forceps, polypectomy snares and EUS needles.

MARKET REPORT DATA TYPES INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends

• Procedure Numbers

• COVID-19 Impact Analysis

• Market Drivers & Limiters

• Market Forecasts Until 2028, and Historical Data to 2018

• Recent Mergers & Acquisitions

• Company Profiles and Product Portfolios

• Leading Competitors

PROCEDURE NUMBERS

A growing number of patients are experiencing symptoms of disorders or abnormalities in their GI tracts, driving the growth in tissue biopsy procedures. The use of biopsy forceps to remove polyps and samples has also increased as a result of technological advances in diagnostic procedures.

GLOBAL BIOPSY FORCEPS, POLYPECTOMY SNARES, AND EUS NEEDLE DEVICE MARKET TRENDS

Over the past few years, disposable biopsy forceps have become more popular due to a sharp decline in their price. Due to tighter budgets throughout the COVID-19 pandemic, pricing dipped and recovered in 2020 and 2021, but pricing is expected to decline steadily throughout the remainder of the forecast period. As a result of the lower price, surgeons are more likely to use the devices, and unit sales are higher.

GLOBAL BIOPSY FORCEPS, POLYPECTOMY SNARES, AND EUS NEEDLE DEVICE MARKET SHARE INSIGHTS

Overall, within the global anti-reflux device market there are three dominant competitors: Boston Scientific, Cook Medical, and Olympus. Boston Scientific held just under half of the total market share in 2021 for biopsy forceps, polypectomy snares, and EUS. Boston Scientific has achieved success in both biopsy forceps and EUS needles.

GLOBAL HEMOSTASIS DEVICE MARKET SEGMENTATION SUMMARY

• Biopsy Forceps Market - Including:
  • Cold Disposable, Hot Disposable, Cold Reusable, and Hot Reusable Biopsy Forceps.
  • Polypectomy Snare Market
  • EUS Needle Market

RESEARCH SCOPE SUMMARY

• Regions - North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

• Base Year - 2021
• Forecast - 2022-2028
• Historical Data - 2018-2021

• Quantitative Coverage - Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.

• Qualitative Coverage - COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.

• Data Sources - Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE iDATA?

• Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

• Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

• Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

• Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

• Work with us, and you'll work with seasoned professionals - vigilant of deadlines, and committed to providing the most up-to-date, accurate medical device market research.